RUTH L KATZ to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications RUTH L KATZ has written about In Situ Hybridization, Fluorescence.
Connection Strength
3.234
-
Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study. Cancer Cytopathol. 2010 Oct 25; 118(5):259-68.
Score: 0.257
-
A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis. Cancer Cytopathol. 2010 Aug 25; 118(4):175-83.
Score: 0.254
-
Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res. 2010 Aug 01; 16(15):3976-87.
Score: 0.252
-
Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful for predicting survival. Cancer. 2008 Oct 25; 114(5):315-22.
Score: 0.223
-
3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol. 2008 Sep; 3(9):979-84.
Score: 0.221
-
The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens. Cancer. 2005 Apr 25; 105(2):110-8.
Score: 0.175
-
Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings. Mod Pathol. 2004 May; 17(5):553-60.
Score: 0.164
-
Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping. Cancer. 2003 Dec 25; 99(6):385-93.
Score: 0.160
-
Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization. Diagn Cytopathol. 2003 Aug; 29(2):61-6.
Score: 0.155
-
Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in cytology. Diagn Mol Pathol. 2002 Mar; 11(1):47-57.
Score: 0.141
-
Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer. J Cancer Res Clin Oncol. 2021 Aug; 147(8):2397-2405.
Score: 0.131
-
Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma. Am J Clin Pathol. 2000 Aug; 114(2):248-57.
Score: 0.126
-
Numeric chromosomal abnormalities in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration biopsies. Cancer. 2000 Apr 25; 90(2):126-32.
Score: 0.124
-
Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules. Cancer Cytopathol. 2020 08; 128(8):553-562.
Score: 0.124
-
Novel fluorescence in?situ hybridization-based definition of bacille Calmette-Gu?rin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies. BJU Int. 2016 May; 117(5):754-60.
Score: 0.089
-
Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Gu?rin therapy for bladder cancer: results of a prospective trial. J Urol. 2012 Mar; 187(3):862-7.
Score: 0.070
-
The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer. Urol Oncol. 2012 Nov-Dec; 30(6):821-4.
Score: 0.066
-
Computerized analysis of cytology and fluorescence in situ hybridization (FISH) in induced sputum for lung cancer detection. Cancer Cytopathol. 2010 Oct 25; 118(5):269-77.
Score: 0.064
-
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol. 2008 Aug; 21(8):950-60.
Score: 0.054
-
Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol. 2008 Jul; 110(1):37-42.
Score: 0.054
-
Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer. Clin Cancer Res. 2005 Aug 01; 11(15):5417-24.
Score: 0.045
-
Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia. 2004 Sep-Oct; 6(5):623-35.
Score: 0.042
-
Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer. 2003 Sep 20; 106(5):661-5.
Score: 0.039
-
Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS): An international, multi-institutional study. Cancer Cytopathol. 2023 11; 131(11):679-692.
Score: 0.039
-
Rapid detection of IgH/BCL2 rearrangement in follicular lymphoma by interphase fluorescence in situ hybridization with bacterial artificial chromosome probes. J Mol Diagn. 2002 Aug; 4(3):144-9.
Score: 0.036
-
Fine-needle aspiration diagnosis of lymphomas with signet ring cell features: potential pitfalls and solutions. Cancer Cytopathol. 2013 Sep; 121(9):525-32.
Score: 0.019
-
Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. 2012 May 31; 31(22):2794-804.
Score: 0.017
-
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer. J Pathol. 2009 Aug; 218(4):505-13.
Score: 0.015
-
Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst. 2008 Oct 01; 100(19):1401-11.
Score: 0.014
-
Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis. Cancer. 2008 Aug 25; 114(4):275-83.
Score: 0.014
-
Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):482-7.
Score: 0.012
-
Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene. 2006 Apr 27; 25(18):2628-35.
Score: 0.012
-
Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations. Cancer. 2005 Feb 25; 105(1):35-43.
Score: 0.011
-
Chromosome X numerical abnormalities in patients with non-Hodgkin's lymphoma. A study of 59 patients using fluorescence in situ hybridization. Cancer Genet Cytogenet. 1995 Jul 01; 82(1):23-9.
Score: 0.006
-
High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement. Cancer Genet Cytogenet. 1994 Oct; 77(1):39-44.
Score: 0.005
-
Polysomy of chromosome 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphoma. Genes Chromosomes Cancer. 1994 Mar; 9(3):161-7.
Score: 0.005